Food Companies Rethink Menus For GLP-1 Users As Wegovy Weight Loss Pill Gets Approval
On Tuesday, the U.S. Food and Drug Administration (FDA) approved Novo Nordisk A/S' (NYSE:NVO) Wegovy pill (once-daily oral semaglutide 25 mg) to reduce excess body weight and maintain weight reduction long term and to reduce the risk of major …